Categories Earnings, Industrials

Deere (DE) Q4 2019 Earnings Snapshot

— Deere & Company (NYSE: DE) reported its fourth-quarter 2019 adjusted earnings of $2.14 per share versus $2.13 per share expected.

— Total revenues increased by 5% to $9.9 billion. Sales in Equipment Operations rose by 4% to $8.7 billion versus $8.53 billion expected.

Deere (DE) Q4 2019 Earnings Snapshot

— The results reflected continued uncertainties in the agricultural sector. Many farmers remained cautious about making major investments in new equipment due to lingering trade tensions as well as difficult growing and harvesting conditions.

— Sales in Agriculture & Turf rose 3% to $5.8 billion due to price realization and higher shipment volumes, partially offset by the unfavorable effects of currency translation.

— Construction & Forestry sales grew by 8% to $2.95 billion helped by higher shipment volumes and price realization, partially offset by the unfavorable effects of currency translation.

— Financial Services posted a 66% dip in net income to $90 million, mainly due to impairments and higher losses on operating-lease residual values and unfavorable financing spreads.

— Looking ahead into fiscal 2020, net income attributable to Deere & Company is forecast to be in the range of $2.7 billion to $3.1 billion. The long-term outlook for its businesses remained healthy and points a promising future.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Also Read:  Marathon Petroleum Corp. (MPC): Q4 2019 Earnings Snapshot

Most Popular

BlackBerry (BB) likely to report weak Q4 earnings on March 31

BlackBerry Limited (NYSE: BB) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 31, after the market closes. The top line will be benefited by BlackBerry Cylance

Companies that are working on the coronavirus vaccine

The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the US alone. As the world grapples with the outbreak, several

Altimmune (ALT) reports FY19 results; announces vaccine candidate for COVID-19

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues was caused by lower billings

Tags